48,469
edits
Difference between revisions of "Atypical fibroxanthoma"
Jump to navigation
Jump to search
→IHC
(→IHC) |
(→IHC) |
||
| Line 76: | Line 76: | ||
**Scant staining not considered +ve. | **Scant staining not considered +ve. | ||
*Desmin -ve (done to r/o leiomyosarcoma). | *Desmin -ve (done to r/o leiomyosarcoma). | ||
*[[CD99]] +ve.<ref name=pmid11789717>{{Cite journal | last1 = Monteagudo | first1 = C. | last2 = Calduch | first2 = L. | last3 = Navarro | first3 = S. | last4 = Joan-Figueroa | first4 = A. | last5 = Llombart-Bosch | first5 = A. | title = CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. | journal = Am J Clin Pathol | volume = 117 | issue = 1 | pages = 126-31 | month = Jan | year = 2002 | doi = 10.1309/2EXB-70CW-3U6P-VQ6H | PMID = 11789717 }}</ref> | |||
**Usually +ve in [[melanoma]]... but negative in [[squamous carcinoma]]. | |||
Others: | Others: | ||